HIV-1 non-b subtypes in Italy: A growing trend

New Microbiologica

Volumn 35, Issue 4, 2012, Pages 377-386

  Ciccozzi, Massimo ^a   Santoro, Maria Mercedes ^b   Giovanetti, Marta ^a   Andrissi, Laura ^d   Bertoli, Ada ^b,c   Ciotti, Marco ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b UNIVERSITY OF ROME TOR VERGATA   (Italy)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^d SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Genotypic resistance test; HIV 1 non B subtypes in Italy; Phylogeny

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT;

ARTICLE; CLASSIFICATION; DRUG EFFECT; GENETICS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ISOLATION AND PURIFICATION; ITALY; VIROLOGY;

ANTI-HIV AGENTS; HIV INFECTIONS; HIV-1; HUMANS; ITALY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84869154988     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (77)

1. ABECASIS A.B., DEFORCHE K., SNOECK J., BACHELER L.T., MCKENNA P., CARVALHO A.P., GOMES P., CAMACHO R.J., VANDAMME A.M. (2005). Protease mutation M89I/V is linked to therapy failure in patients infected with the HIV-1 non-B subtypes C, F or G. AIDS. 19, 1799-1806. (Pubitemid 41546598)
2. BALDANTI F., PAOLUCCI S., RAVASI G., MACCABRUNI A., MORIGGIA A., BARBARINI G., MASERATI R. (2008). Changes in circulation of B and non-B HIV strains: spotlight on a reference centre for infectious diseases in Northern Italy. J. Med. Virol. 80, 947-952. (Pubitemid 351657003)
3. BALOTTA C., FACCHI G., VIOLIN M., VAN DOOREN S., COZZI-LEPRI A., FORBICI F., BERTOLI A., RIVA C., SENESE D., CARAMELLO P., CARNEVALE G, RIZZARDINI G., CREMONINI L., MONNO L., REZZA G., PERNO C.F., IPPOLITO G., D'ARMINIO-MONFORTE A., VANDAMME A.M., MORONI M.; ICONA STUDY GROUP. (2001). Increasing prevalence of non-clade B HIV-1 strains in heterosexual men and women, as monitored by analysis of reverse transcriptase and protease sequences. J. Acquir. Immune. Defic. Syndr. 27, 499-505. (Pubitemid 32801080)
4. BON I., CICCOZZI M., ZEHENDER G., BIAGETTI C., VERRUCCHI G., LAI A., LO PRESTI A., GIBELLINI D., RE M.C. (2010). HIV-1 subtype C transmission network: the phylogeneticreconstruction strongly supports the epidemiological data. J. Clin. Virol. 48, 212-214.
5. BRACCIALE L., COLAFIGLI M., ZAZZI M., CORSI P., MERAVIGLIA P., MICHELI V., MASERATI R., GIANOTTI N., PENCO G., SETTI M., DI GIAMBENEDETTO S., BUTINI L., VIVARELLI A., TREZZI M., DE LUCA A. (2009). Prevalence of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy: evolution over 12 years and predictors. J. Antimicrob. Chemother. 64, 607-615.
6. BRENNER B., TURNER D., OLIVEIRA M., MOISI D., DETORIO M., CAROBENEM., MARLINKR.G., SCHAPIRO J., ROGER M., WAINBERG M.A. (2003). A V106M mutation in HIV-1 clade C viruses exposed to efavirenz confers cross-resistance to non-nucleoside reverse tran-scriptase inhibitors. AIDS. 17, F1-F5. (Pubitemid 36106291)
7. BRENNER B.G., OLIVEIRA M., DOUALLA-BELL F., MOISI D.D., NTEMGWA M., FRANKEL F., ESSEX M., WAINBERG M.A. (2006). HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture. AIDS. 20, F9-F13. (Pubitemid 44030369)
8. BRENNER B.G., LOWE M., MOISI D., HARDY I., GAGNON S., CHAREST H., BARIL J.G., WAINBERG M.A., ROGER M. (2011.) Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors. J. Med. Virol. 83, 751-759.
9. BUONAGURO L., TAGLIAMONTE M., TORNESELLO M.L., PILOTTI E., CASOLI C., LAZZARIN A., TAMBUSSI G., CICCOZZI M., REZZA G., BUONAGURO F.M. (2004). Italian Concerted Action on PHI Treatment. Screening of HIV-1 isolates by reverse heterodu-plex mobility assay and identification of non-B subtypes in Italy. J. Acquir. Immune. Defic. Syndr. 37, 1295-1306. (Pubitemid 39281512)
10. BUONAGURO L., TAGLIAMONTE M., TORNESELLO M.L., BUONAGURO F.M. (2007). Genetic and phylogenetic evolution of HIV-1 in a low subtype heterogeneity epidemic: the Italian example. Retrovir. 21, 4-34.
11. BUONAGURO L., PETRIZZO A., TAGLIAMONTE M., VITONE F., RE M.C., PILOTTI E., CASOLI C., SBREGLIA C., PERRELLA O., TORNESELLO M.L., BUONAGURO F.M. (2008). Molecular and phylogenetic analysis of HIV-1 variants circulating in Italy. Infect. Agent. Cancer. 10, 3-13.
12. BUTLER J., LIDWELL W., HOLDEN K. (2010). Universal principles of design. Gloucester, MA, Rockport Publishers.
13. CALAZANS A., BRINDEIRO R., BRINDEIRO P., VERLI H., ARRUDA M.B., GONZALEZ L.M., GUIMARAES J.A., DIAZ R.S., ANTUNES O.A., TANURI A. (2005). Low accumulation of L90M in protease from subtype F HIV-1 with resistance to protease inhibitors is caused by the L89M polymorphism. J. Infect. Dis. 191, 1961-1970. (Pubitemid 40705405)
14. CALLEGARO A., SVICHER V., ALTERI C., LO PRESTI A., VALENTI D., GOGLIO A., SALEMI M., CELLA E., PERNO C.F., CICCOZZI M., MAGGIOLO F. (2011). Epidemiological network analysis in HIV-1 B infected patients diagnosed in Italy between 2000 and 2008. Infect. Genet. Evol. 11, 624-632.
15. CANE P.A., DE RUITER A., RICE P., WISELKA M., FOX R., PILLAY D. (2001). Resistance-associated mutations in the human immunodeficiency virus type 1 subtype C protease gene from treated and untreated patients in the United Kingdom. J. Clin. Microbiol. 39, 2652-2654. (Pubitemid 32606251)
16. CHAIX M.L., DESCAMPS D., HARZIC M., SCHNEIDER V., DEVEAU C., TAMALET C., PELLEGRIN I., IZOPET J., RUFFAULT A., MASQUELIER B., MEYER L., ROUZIOUX C., BRUN-VEZINET F., COSTAGLIOLA D. (2003). Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France. AIDS. 17, 2635-2643. (Pubitemid 38402342)
17. CHILTON D.N., CASTRO H., LATTIMORE S., HARRISON L.J., FEARNHILL E., DELPECH V., RICE B., PILLAY D., DUNN D.T. UK Collaborative Group on HIV Drug Resistance. (2010). HIV type-1 drug resistance in antiretroviral treatment-naive adults infected with non-B subtype virus in the United Kingdom. Antivir. Ther. 15, 985-991.
18. CICCOZZI M., MONTIERI S., SALEMI M., DE OLIVEIRA T., DORRUCCI M., SINICCO A., DE LUCA A., GIULIANI M., BALOTTA C., REZZA G. (2007) An outbreak of HIV-1 subtype G among Italian injecting drug users. AIDS. 21, 1213-1215. (Pubitemid 46763295)
19. CICCOZZI M., BON I., CIOTTI M. (2010). Do the HIV-1 subtypes circulating in Italy resemble the Red Queen running in Carroll's novel? New Microbiol. 33, 179-181.
20. CICCOZZI M., VUJOŠEVI D., LO PRESTI A., MUGOŠA B., VRATNICA Z., LAI A., LAUŠEVI D., DRAŠKOVI N., MARJANOVIC A., CELLA E., SANTORO M.M., ALTERI C., FABENI L., CIOTTI M., ZEHENDER G. (2011). Genetic diversity of HIV type 1 in Montenegro. AIDS. Res. Hum. Retrovir. 27, 921-924.
21. CICCOZZI M., LAI A., EBRANATI E., GABANELLI E., GALLI M., MUGOSA B., VRATNICA Z., VUJOŠEVIC D., LAUŠEVIC D., CIOTTI M., CELLA E., LO PRESTI A., ZEHENDER G. (2012). Phylogeographic Reconstruction of HIV Type 1B in Montenegro and the Balkan Region. AIDS Res Hum Retrovir. [Epub ahead of print].
22. COLAFIGLI M., TORTI C., TRECARICHI E.M., ALBINI L., ROSI A., MICHELI V., MANCA N., PENCO G., BRUZZONE B., PUNZI G., CORSI P., PARRUTI G., BAGNARELLI P., MONNO L., GONNELLI A., CAUDA R., DI GIAMBENEDETTO S.; ON BEHALF OF THE ARCA, UCSC AND BRESCIA HIV RESISTANCE STUDY GROUPS. (2012). Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010. Clin. Microbiol. Infect. 18, E299-E304.
23. COUTSINOS D., INVERNIZZI C.F., XU H., MOISI D., OLIVEIRA M., BRENNER B.G., WAINBERG M.A. (2009). Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1. J. Virol. 83, 2029-2033.
24. DESCAMPS D., CHAIX M.L., MONTES B., PAKIANATHER S., CHARPENTIER C., STORTO A., BARIN F., DOS SANTOS G., KRIVINE A., DELAUGERRE C., IZOPET J., MARCELIN A.G., MAILLARD A., MORAND-JOUBERT L., PALLIER C., PLANTIER J.C., TAMALET C., COTTALORDA J., DESBOIS D., CALVEZ V., BRUN-VEZINET F., MASQUELIER B., COSTAGLIOLA D. ANRS AC11 RESISTANCE STUDY GROUP. (2010). Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-in-fected patients from 2001 to 4. 2006/2007 in France. J. Antimicrob. Chemother. 65, 2620-2627.
25. DE OLIVEIRA T., PYBUS O.G., RAMBAUT A., SALEMI M., CASSOL S., CICCOZZI M., REZZA G., GATTINARA G.C., D'ARRIGO R., AMICOSANTE M., PERRIN L., COLIZZI V., PERNO C.F. BENGHAZI STUDY GROUP. (2006). Molecular epidemiology: HIV-1 and HCV sequences from Libyan outbreak. Nature. 444, 836-837. (Pubitemid 46024988)
26. DE PASCHALE M., CAGNIN D., CERULLI T., MENA M., MAGNANI C., PERINI P., RE T., VILLA M., VIGANÒ P., MALTEMPO C., MANCO M.T., AGRAPPI C., MIRRI P., GATTI A., RESCALDANI C., CLERICI P. (2011). Epidemiology of HIV-1 subtypes in an urban area of northern Italy. Clin. Microbiol. Infect. 17, 935-940.
27. DOUALLA-BELL F., AVALOS A., BRENNER B., GAOLATHE T., MINE M., GASEITSIWE S., OLIVEIRA M., MOISI D., NDWAPI N., MOFFAT H., ESSEX M., WAINBERG M.A. (2006). High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens. Antimicrob. Ag. Chemother. 50, 4182-4185. (Pubitemid 44865165)
28. EUROPEAN AIDS CLINICAL SOCIETY GUIDELINES (EACS). Guidelines for the Clinical Management and Treatment of HIV infected adults in Europe; Version 6, October 2011. Available online at http://www.europeanaidsclinicalsociety.org/
29. FELSENSTEIN J. (2004). Inferring Phylogenies. Sinauer Associates, Sunderland, MA.
30. FITCH W.M., MARGOLIASH E. (1967). Construction of phylogenetic trees. Science. 155, 279-284.
31. FRANZETTI M., LAI A., SIMONETTI F.R., BOZZI G., DE LUCA A., MICHELI V., MERAVIGLIA P., CORSI P., BAGNARELLI P., ALMI P., ZONCADA A., BALOTTA C. (2012). High burden of transmitted HIV-1 drug resistance in Italian patients carrying F1 subtype. J. Antimicrob. Chemother. 67, 1250-1253.
32. FRANZETTI M., VIOLIN M., CASAZZA G., MEINI G., CALLEGARO A., CORSI P., MAGGIOLO F., PIGNATARO A.R., PAOLUCCI S., GIANOTTI N., FRANCISCI D., ROSSOTTI R., FILICE G., CARLI T., ZAZZI M., BALOTTA C. (2012). Human immunodeficiency virus-1 B and non-B subtypes with the same drug resistance pattern respond similarly to antiretroviral therapy. Clin. Microbiol. Infect. 18, E66-E70.
33. GARCÍA-LERMA J.G., MACINNES H., BENNETT D., REID P., NIDTHA S., WEINSTOCK H., KAPLAN J.E., HENEINE W. (2003). A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation. J. Virol. 77, 5685-5693. (Pubitemid 36538961)
34. GIFFORD R.J., DE OLIVEIRA T., RAMBAUT A., PYBUS O.G., DUNN D., VANDAMME A.M., KELLAM P., PILLAY D., UK COLLABORATIVE GROUP ON HIV DRUG RESISTANCE. (2007). Phylogenetic surveillance of viral genetic diversity and the evolving molecular epidemiology of human immunodeficiency virus type 1. J. Virol. 81, 13050-13056. (Pubitemid 350156943)
35. GIULIANI M., MONTIERI S., PALAMARA G., LATINI A., ALTERI C., PERNO C.F., SANTORO M.M., REZZA G., CICCOZZI M. (2009). Non-B HIV type 1 subtypes among men who have sex with men in Rome, Italy. AIDS Res. Hum. Retrovir. 25, 157-164.
36. GONZALEZ L.M., SANTOS A.F., ABECASIS A.B., VAN LAETHEM K., SOARES E.A., DEFORCHE K., TANURI A., CAMACHO R., VANDAMME A.M., SOARES M.A. (2008). Impact of HIV-1 protease mutations A71V/T and T74S on M89I/V-mediated protease inhibitor resistance in subtype G isolates. J. Antimicrob. Chemother. 61, 1201-1204. (Pubitemid 351753582)
37. GROSSMAN Z., ISTOMIN V., AVERBUCH D., LORBER M., RISENBERG K., LEVI I., CHOWERS M., BURKE M., BAR YAACOV N., SCHAPIRO J.M. Israel AIDS Multi-Center Study Group. (2004). Genetic variation at NNRTI resistance-associated positions in patients infected with HIV-1 subtype C. AIDS. 18, 909-915. (Pubitemid 38553711)
38. HEMELAAR J., GOUWS E., GHYS P.D., OSMANOV S. (2006). Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS. 20, W13-W23. (Pubitemid 44611051)
39. HEMELAAR J., GOUWS E., GHYS P.D., OSMANOV S. WHO-UNAIDS Network for HIV Isolation and Characterisation. (2011). Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 13, 679-689.
40. HIRSCH M.S., GÜNTHARD H.F., SCHAPIRO J.M., BRUN-VÉZINET F., CLOTET B., HAMMER S.M., JOHNSON V.A., KURITZKES D.R., MELLORS J.W., PILLAY D., YENI P.G., JACOBSEN D.M., RICHMAN D.D. (2008). Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel. Clin. Infect. Dis. 47, 266-285. (Pubitemid 351920631)
41. KANTOR R., SHAFER R.W., KATZENSTEIN D. (2005). HIV-1 Non-subtype B Workgroup: the HIV-1 Non-subtype B Workgroup: an international collaboration for the collection and analysis of HIV-1 non-subtype B data. Med. Gen. Med. 23, 7-71.
42. INVERNIZZI C.F., COUTSINOS D., OLIVEIRA M., MOISI D., BRENNER B.G., WAINBERG M.A. (2009). Signature nucleotide polymorphisms at positions 64 and 65 in reverse transcriptase favor the selection of the K65R resistance mutation in HIV-1 subtype C. J. Infect. Dis. 200, 1202-1206.
43. ISTITUTO SUPERIORE DI SANITÀ. (2011). L'epidemiologia dell'HIV/AIDS in Italia: i dati del Centro Operativo AIDS dell'Istituto Superiore di Sanità, Available online at: www.epicentro.iss.it/problemi/ aids/pdf/Coa 2011-commento.pdf
44. LAI A., RIVA C., MARCONI A., BALESTRIERI M., RAZZOLINI F., MEINI G., VICENTI I., ROSI A., SALADINI F., CARAMMA I., FRANZETTI M., ROSSINI V., GALLI A., GALLI M., VIOLIN M., ZAZZI M., BALOTTA C. (2010). Changing patterns in HIV-1 non-B clade prevalence and diversity in Italy over three decades. HIV Med. 11, 593-602.
45. LEMEY P., SALEMI M., VANDAMME A.-M., EDS. (2009). The phylogenetic handbook: a practical approach to phylogenetic analysis and hypothesis testing. NY: Cambridge University Press.
46. LONGO B., NOVATI S., MONTIERI S., PONTALI E., TAGLIA F., LEO G., BABUDIERI S., STARNINI G., MONARCA R., SULIGOI B., REZZA G., CICCOZZI M., ITALIAN STUDY GROUP ON HIV IN PRISON. (2008). HIV-1 diversity among inmates of Italian prisons. J. Med. Virol. 80, 1689-1694.
47. LOSPITAO E., ALVAREZ A., SORIANO V., HOLGUIN A. (2005). HIV-1 subtypes in Spain: a retrospective analysis from 1995 to 2003. HIV Med. 6, 313-320. (Pubitemid 41335139)
48. MAÏGA A.I., MALET I., SOULIE C., DERACHE A., KOITA V., AMELLAL B., TCHERTANOV L., DELELIS O., MORAND-JOUBERT L., MOUSCADET J.F., MURPHY R., CISSÉ M., KATLAMA C., CALVEZ V., MARCELIN A.G. (2009). Genetic barriers for integrase inhibitor drug resistance in HIV type-1 B and CRF02-AG subtypes. Antivir. Ther. 14, 123-129.
49. MILLER M.D., MARGOT N., MCCOLL D., CHENG A.K. (2007). K65R development among subtype C HIV-1 patients in tenofovir DF clinical trials. AIDS 21, 265-266. (Pubitemid 46036948)
50. MONNO L., BRINDICCI G., LO CAPUTO S., PUNZI G., SCARABAGGIO T., RIVA C., DI BARI C, PIEROTTI P., SARACINO A., LAGIOIA A., MAZZOTTA F., BALOTTA C., ANGARANO G. (2005). HIV-1 subtypes and circulating recombinant forms (CRFs) from HIV-infected patients residing in two regions of central and southern Italy. J. Med. Virol. 75, 483-490. (Pubitemid 40293514)
51. MONNO L., SCUDELLER L., BRINDICCI G., SARACINO A., PUNZI G., CHIRIANNI A., LAGIOIA A., LADISA N., LO CAPUTO S., ANGARANO G. (2009). Genotypic analysis of the protease and reverse transcriptase of non-B HIV type 1 clinical isolates from naïve and treated subjects. Antivir. Res. 83, 118-126.
52. PALMA A.C., ARAUJO F., DUQUE V., BORGES F., PAIXAO M.T., CAMACHO R., PORTUGUESE SPREAD NETWORK. (2007). Molecular epidemiology and prevalence of drug resistance-associated mutations in newly diagnosed HIV-1 patients in Portugal. Infect. Genet. Evol. 7, 391-398. (Pubitemid 46667770)
53. PALMA A.C., COVENS K., SNOECK J., VANDAMME A.M., CAMACHO R.J., VAN LAETHEM K. (2012). HIV-1 protease mutation 82M contributes to phenotypic resistance to protease inhibitors in subtype G. J. Antimicrob. Chemother. 67, 1075-1079.
54. PEETERS M, AGHOKENG A.F., DELAPORTE E. (2010). Genetic diversity among human immunodeficiency virus-1 non-B subtypes in viral load and drug resistance assays. Clin. Microbiol. Infect. 16, 1525-1531.
55. PIRALLA A., PAOLUCCI S., GULMINETTI R., COMOLLI G., BALDANTI F. (2011). HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients. Virol. J. 8, 149.
56. POL D. (2004). Empirical problems of the hierarchical likelihood ratio test for model selection. Syst. Biol. 53, 949-962. (Pubitemid 40141317)
57. RIVA C., LAI A., CARAMMA I., CORVASCE S., VIOLIN M., DEHÒ L., PRATI F., ROSSI C., COLOMBO M.C., CAPETTI A., FRANZETTI M., ROSSINI V., TAMBUSSI G., CICCOZZI M., SULIGOI B., MUSSINI C., REZZA G., BALOTTA C. (2010). Transmitted HIV Type 1 drug resistance and Non-B subtypes prevalence among seroconverters and newly diagnosed patients from 1992 to 2005 in Italy. AIDS Res. Hum. Retrovir. 26, 41-49.
58. ROSSOTTI R., FOGLIENI B., MOLTENI C., GATTI M., GUARNORI I., LA RUSSA E., PRATI D., ORANI A. (2011). A cluster of patients with recombinant B/F HIV-1 infection: epidemiological, clinical, and virological aspects. J. Med. Virol. 83, 493-498.
59. SAITOU N, NEI M. (1987). The neighbor-joining method: a new method for reconstructing phylogenetic trees. Mol. Biol. Evol. 4, 406-425.
60. SALADINI F., FOLEY B.T., ROSI A., VICENTI I., NANNETTI G., MEINI G., RAZZOLINI F., ZAZZI M. (2012). Near full-length sequence analysis of HIV type 1 BF recombinants from Italy. AIDS Res. Hum. Retrovir. 28, 299-303.
61. SALEMI M., GOODENOW M.M., MONTIERI S., DE OLIVEIRA T., SANTORO M.M., BESHKOV D., ALEXIEV I., ELENKOV I., ELENKOV I., YAKIMOVA T., VARLEVA T., REZZA G., CICCOZZI M. (2008). The HIV type 1 epidemic in Bulgaria involves multiple subtypes and is sustained by continuous viral inflow from West and East European countries. AIDS Res. Hum. Retrovir. 24, 771-779. (Pubitemid 351876981)
62. SALPINI R., ALTERI C., GORI C., STAZI F., BERTOLI A., MAFFONGELLI G., ZACCARELLI M., ARMENIA D., NARCISO P., ANTINORI A., GIULIANI M., PALAMARA G., ANDREONI M., SVICHER V., CECCHERINI-SILBERSTEIN F., SANTORO M.M., PERNO C.F. (2011). Characterization of HIV-1 infection among immigrants to Italy: implications for HIV/AIDS surveillance. 6th IAS conference on HIV pathogenesis, treatment and prevention. Rome, Italy. Abstract MO-PE374.
63. SANTORO M.M., ALTERI C., RONGA L., FLANDRE P., FABENI L., MERCURIO F., D'ARRIGO R., GORI C., PALAMARA G., BERTOLI A., FORBICI F, SALPINI R., BOUMIS E., TOZZI V., VISCO-COMANDINI U., ZACCARELLI M., VAN HOUTTE M., PATTERY T., NARCISO P., ANTINORI A., CECCHERINI-SILBERSTEIN F., PERNO C.F. (2012). Comparative Analysis of Drug Resistance Among B and the Most Prevalent Non-B HIV Type 1 Subtypes (C, F, and CRF02-AG) in Italy. AIDS Res. Hum. Retrovir. [Epub ahead of print].
64. SNOECK J., VAN LAETHEM K., HERMANS P., VAN WIJNGAERDEN E., DERDELINCKX I., SCHROOTEN Y., VAN DE VIJVER D.A., DE WIT S., CLUMECK N., VANDAMME A.M. (2004). Rising prevalence of HIV-1 non-B subtypes in Belgium: 1983-2001. J. Acquir. Immune. Defic. Syndr. 35, 279-285. (Pubitemid 38280654)
65. SONNERBORG A., DURDEVIC S., GIESECKE J., SÄLLBERG M. (1997). Dynamics of the HIV-1 subtype distribution in the Swedish HIV-1 epidemic during the period 1980 to 1993. AIDS Res. Hum. Retrovir. 13, 343-345. (Pubitemid 27117947)
66. SUGIURA W., MATSUDA Z., YOKOMAKU Y., HERTOGS K., LARDER B., OISHI T., OKANO A., SHIINO T., TATSUMI M., MATSUDA M., ABUMI H., TAKATA N., SHIRAHATA S., YAMADA K., YOSHIKURA H., NAGAI Y. (2002). Interference between D30N and L90M in selection and development of protease inhibitor-resistant human immunodeficiency virus type 1. Antimicrob. Ag. Chemother. 46, 708-715. (Pubitemid 34157655)
67. TAGLIAMONTE M., VIDAL N., TORNESELLO M.L., PEETERS M., BUONAGURO F.M., BUONAGURO L. (2006) Genetic and phylogenetic characterization of structural genes from non-B HIV-1 subtypes in Italy. AIDS Res Hum Retroviruses. 22, 1045-1051. (Pubitemid 46100691)
68. THE US DEPARTMENT OF HEALTH AND HUMAN SERVICES [DHHS]. Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. US Department of Health and Human Services. 2012 Mar; 1-239. Available online at http://www.aidsinfo.nih.gov/contentfiles/adultan-dadolescentgl.pdf
69. TRAMUTO F., VITALE F., BONURA F., ROMANO N., GROUP FOR HIV-1 ANTIRETROVIRAL STUDIES IN SICILY. (2004). Detection of HIV type 1 non-B subtypes in Sicily, Italy. AIDS Res. Hum. Retrovir. 20, 251-254. (Pubitemid 38280937)
70. TORTI C., LAPADULA G., IZZO I., BRINDICCI G., LABBATE G., QUIROS-ROLDAN E., DIALLO I., GARGIULO F., CASTELNUOVO F., CALABRESI A., CAROSI G., MANCA N., MONNO L. (2010). Heterogeneity and penetration of HIV-1 non-subtype B viruses in an Italian province: public health implications. Epidemiol. Infect. 138, 1298-1307.
71. VAN DE VIJVER D.A., WENSING A.M., ANGARANO G., ASJÖ B., BALOTTA C., BOERI E., CAMACHO R., CHAIX M.L., COSTAGLIOLA D., DE LUCA A., DERDELINCKX I., GROSSMAN Z., HAMOUDA O., HATZAKIS A., HEMMER R., HOEPELMAN A., HORBAN A., KORN K., KÜCHERER C., LEITNER T., LOVEDAY C., MACRAE E., MALJKOVIC I., DE MENDOZA C., MEYER L., NIELSEN C., OP DE COUL E.L., ORMAASEN V., PARASKEVIS D., PERRIN L., PUCHHAMMER-STÖCKL E., RUIZ L., SALMINEN M., SCHMIT J.C., SCHNEIDER F., SCHUURMAN R., SORIANO V., STANCZAK G., STANOJEVIC M., VANDAMME A.M., VAN LAETHEM K., VIOLIN M., WILBE K., YERLY S., ZAZZI M., BOUCHER C.A. (2006). The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes. J. Acquir. Immune. Defic. Syndr. 41, 352-360.
72. VANDAMME A.M., CAMACHO R.J., CECCHERINI-SILBERSTEIN F., DE LUCA A., PALMISANO L., PARASKEVIS D., PAREDES R., POLJAK M., SCHMIT J.C., SORIANO V., WALTER H., SÖNNERBORG A. (2011). European HIV Drug Resistance Guidelines Panel. European recommendations for the clinical use of HIV drug resistance testing: 2011 update. AIDS Rev. 13, 77-108.
73. VÉRAS N.M., SANTORO M.M., GRAY R.R., TATEM A.J., LO PRESTI A., OLEARO F., CAPPELLI G., COLIZZI V., TAKOU D., TORIMIRO J., RUSSO G., CALLEGARO A., SALPINI R., D'ARRIGO R., PERNO C.F., GOODENOW M.M., CICCOZZI M., SALEMI M. (2011). Molecular epidemiology of HIV type 1 CRF02-AG in Cameroon and African patients living in Italy. AIDS Res. Hum. Retrovir. 27, 1173-1182.
74. YANG Z., RANNALA B. (1997). Bayesian phylogenetic inference using DNA sequences: a Markov chain Monte Carlo method. Mol. Biol. and Evol. 14, 717-724. (Pubitemid 27287292)
75. YERLY S., VON WYL V., LEDERGERBER B., BÖNI J., SCHÜPBACH J., BÜRGISSER P., KLIMKAIT T., RICKENBACH M., KAISER L., GÜNTHARD H.F., PERRIN L. (2007). Swiss HIV Cohort Study. Swiss HIV cohort study. Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey. AIDS. 21, 2223-2229. (Pubitemid 350287221)
76. VISCO-COMANDINI U., BALOTTA C. (2003). Genotypic resistance tests for the management of the HIV-in-fected patient with non-B viral isolates. Scand. J. Infect. Dis. Suppl. 106, 75-8. Review. (Pubitemid 38228557)
77. ZEHENDER G., EBRANATI E., LAI A., SANTORO M.M., ALTERI C., GIULIANI M, PALAMARA G., PERNO C.F., GALLI M., LO PRESTI A., CICCOZZI M. (2010). Population dynamics of HIV-1 subtype B in a cohort of men-having-sex-with-men in Rome, Italy. J. Acquir. Immune. Defic. Syndr. 55, 156-160.